Skip to main content

Myelofibrosis Treatment

Image placeholder title
Myeloproliferative Neoplasms Overviews

Treatment of Myelofibrosis

By Dr. C.H. Weaver M.D.
Second
Myeloproliferative Neoplasms Survivorship

Diagnosed with an MPN? Consider a Second Opinion and See an Expert!

By Dr. C.H. Weaver M.D.
old-g551f4e5fb_1920 copy
Myeloproliferative Neoplasms Overviews

Tips for Confronting Myelofibrosis

By Dr. C.H. Weaver M.D.
Jakafi
Myeloproliferative Neoplasms Treatment

Long Term Survival in Myelofibrosis Improved with Early Use of Jakafi®

By Dr. C.H. Weaver M.D.
Myelofibrosis news Updates
Myeloproliferative Neoplasms Treatment

Jaktinib is a novel selective janus kinase 1-2 inhibitor for people with primary myelofibrosis

By Dr. C.H. Weaver M.D.
Myelofibrosis news Updates
Myeloproliferative Neoplasms Treatment

Jakafi/Selinexor combination evaluated in myelofibrosis

By Dr. C.H. Weaver M.D.
MPN News
Myeloproliferative Neoplasms

Myeloproliferative Neoplasm Update ASH 2021

By Dr. C.H. Weaver M.D.
MPN News
Myeloproliferative Neoplasms Treatment

Dacogen Effective in Advanced Phases of MPN

By Dr. C.H. Weaver M.D.
Myeloproliferative Neoplasms News Updates
Myeloproliferative Neoplasms Survivorship

Study suggests Jakafi not associated with increase in significant secondary malignancies.

By Dr. C.H. Weaver M.D.
MPN News
Myeloproliferative Neoplasms Treatment

Navitoclax-Jakafi combo being evaluated in Myelofibrosis-ASH 2023 Update

By Dr. C.H. Weaver M.D.
Image placeholder title
Myeloproliferative Neoplasms Treatment

BET Inhibitors Treatment of Myelofibrosis

By Dr. C.H. Weaver M.D.
MPN News
Myeloproliferative Neoplasms Treatment

Imetelstat for Myelofibrosis

By Dr. C.H. Weaver M.D.
Image placeholder title
Myeloproliferative Neoplasms Treatment

Inrebic (fedratinib) Treatment of Myelofibrosis

By Dr. C.H. Weaver M.D.
Image placeholder title
Myeloproliferative Neoplasms Treatment

Progress on Pacritinib Development for Treatment of Myelofibrosis

By Dr. C.H. Weaver M.D.
Ojjaara
Myeloproliferative Neoplasms Treatment

FDA Approves Ojjaara for Treatment of Myelofibrosis with Anemia

By Dr. C.H. Weaver M.D.
Image placeholder title
Myeloproliferative Neoplasms Treatment

Jakafi-Interferon Combination “RUXOPEG” Promising for Treatment of Myelofibrosis

By Dr. C.H. Weaver M.D.